Stay updated on Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The site update indicates a new software revision from v3.5.3 to v3.5.4, signaling an incremental platform upgrade. This change relates to the site’s underlying version and does not modify the visible content or features on the page.
    Difference
    0.0%
    Check dated 2026-05-15T03:22:08.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The site revision has been updated from v3.5.2 to v3.5.3, indicating a new software release. This backend update does not alter the visible study details content on the page.
    Difference
    0.0%
    Check dated 2026-04-30T17:36:14.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Updated the displayed region name for the Bordeaux site from “Nouvelle-Aquitaine” to “New Aquitaine,” while retaining the same city and postal code.
    Difference
    0.0%
    Check dated 2026-04-23T14:25:36.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T10:25:09.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    Added Padova, Italy, 35128 and removed Padua, Italy, 35128 from the list of study locations.
    Difference
    0.0%
    Check dated 2026-04-09T08:01:08.000Z thumbnail image
  8. Check
    51 days ago
    Change Detected
    Summary
    Added the term Differentiated thyroid carcinoma and a Resources section linking the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T00:22:34.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.